Citation Tools
Oncolytic and local immunotherapy
Original research
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade